Literature DB >> 26961727

Acromegaly-induced cardiomyopathy with dobutamine-induced outflow tract obstruction.

Mahmoud A Abdelsalam1, Todd B Nippoldt2, Jeffrey B Geske1.   

Abstract

A 50-year-old man with a history of acromegaly was referred for preoperative cardiac evaluation preceding trans-sphenoidal resection of a pituitary macroadenoma. Dobutamine stress echocardiography was negative for myocardial ischaemia. Resting left ventricular (LV) LV ejection fraction (LVEF) was 64% and there was hypertrophy of ventricular septum (18 mm) without resting LV outflow tract obstruction. With 40 µg/kg/min of dobutamine, the LVEF became hyperdynamic at 80%, and there was a maximal instantaneous LV outflow tract gradient of 77 mm Hg. There was no delayed myocardial enhancement on cardiac MRI and the pattern of hypertrophy was concentric. Acromegaly-induced cardiomyopathy can mimic hypertrophic cardiomyopathy in the setting of dobutamine provocation. Because cardiomyopathy is an important cause of mortality in acromegaly, diagnosis and appropriate management are critical to improve survival. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26961727      PMCID: PMC4785418          DOI: 10.1136/bcr-2015-213463

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance.

Authors:  B J Maron
Journal:  Heart       Date:  2005-11       Impact factor: 5.994

Review 2.  A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both?

Authors:  Ernst R Schwarz; Praveen Jammula; Rajiv Gupta; Salvatore Rosanio
Journal:  J Cardiovasc Pharmacol Ther       Date:  2006-12       Impact factor: 2.457

3.  Baseline echocardiographic predictors of dynamic intraventricular obstruction of the left ventricle during dobutamine stress echocardiogram.

Authors:  Edmundo Jose Nassri Câmara; Maristela Magnavita Oliveira; Fábio Maia Ribeiro
Journal:  Echocardiography       Date:  2009-08-28       Impact factor: 1.724

Review 4.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

5.  Basic echocardiographic features of patients with latent left ventricular outflow tract obstruction without left ventricular hypertrophy.

Authors:  Hiroaki Semba; Hitoshi Sawada; Tokuhisa Uejima; Norihiko Takeda; Katsura Soma; Hajime Abe; Takeshi Yamashita; Ryozo Nagai
Journal:  Int Heart J       Date:  2012       Impact factor: 1.862

6.  Long-term outcome of patients with acromegaly and congestive heart failure.

Authors:  Hélène Bihan; Consuelo Espinosa; Hernan Valdes-Socin; Sylvie Salenave; Jacques Young; Suzanne Levasseur; Patrick Assayag; Albert Beckers; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

Review 7.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

Review 8.  Cardiovascular complications in acromegaly: methods of assessment.

Authors:  G Vitale; R Pivonello; M Galderisi; A D'Errico; L Spinelli; G Lupoli; G Lombardi; A Colao
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

9.  A case of reversible dilated cardiomyopathy due to acromegaly with partial empty sella.

Authors:  Shrenik R Doshi; Sachin B Punatar
Journal:  Indian Heart J       Date:  2012-04-28

10.  Congestive heart failure in acromegaly: A review of 6 cases.

Authors:  P Dutta; S Das; A Bhansali; S K Bhadada; B V Rajesh; K S Reddy; K Vaiphei; K K Mukherjee; A Pathak; V N Shah
Journal:  Indian J Endocrinol Metab       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.